Sutro Biopharma (STRO) EPS (Basic) (2017 - 2025)
Sutro Biopharma's (STRO) quarterly EPS (Basic) came in at -$20.78 in Q4 2025, up 23.97% year-on-year from -$16.76 in Q4 2024, and down 3001.49% quarter-over-quarter from -$0.67 in Q3 2025.
Sutro Biopharma (STRO) EPS (Basic) (2017 - 2025) Analysis & Trends
Sutro Biopharma has disclosed EPS (Basic) across 9 years of filings, most recently posting -$20.78 for Q4 2025.
- EPS (Basic) for Q4 2025 came in at -$20.78, up 23.97% year-over-year; the trailing twelve-month figure through Dec 2025 was -$22.5 (up 22.68% YoY), and the FY2025 annual result was -$22.49, up 23.5% from the prior year.
- EPS (Basic) came in at -$20.78 for Q4 2025 at Sutro Biopharma, down from -$0.67 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.52 in Q4 2023 to a low of -$27.33 in Q4 2024.
- The 5-year median for EPS (Basic) is -$0.65 (2021), against an average of -$2.9.
- Across the five-year window, EPS (Basic) surged 185.25% in 2023 and tumbled 5355.77% in 2024, its largest moves.
- Sutro Biopharma's EPS (Basic) stood at -$0.83 in 2021, then rose by 26.51% to -$0.61 in 2022, then soared by 185.25% to $0.52 in 2023, then sank by 5355.77% to -$27.33 in 2024, then grew by 23.97% to -$20.78 in 2025.
- The last three EPS (Basic) figures came in at -$20.78 (Q4 2025), -$0.67 (Q3 2025), and -$0.14 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Sutro Biopharma | 252.04 Mn | 252.04 Mn | - | -20.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.78 |
| Sep 30, 2025 | -0.67 |
| Jun 30, 2025 | -0.14 |
| Mar 31, 2025 | -0.91 |
| Dec 31, 2024 | -27.33 |
| Sep 30, 2024 | -0.59 |
| Jun 30, 2024 | -0.59 |
| Mar 31, 2024 | -0.59 |
| Dec 31, 2023 | 0.52 |
| Sep 30, 2023 | -0.81 |
| Jun 30, 2023 | -0.64 |
| Mar 31, 2023 | -0.85 |
| Dec 31, 2022 | -0.61 |
| Sep 30, 2022 | -0.37 |
| Jun 30, 2022 | -0.55 |
| Mar 31, 2022 | -0.84 |
| Dec 31, 2021 | -0.83 |
| Sep 30, 2021 | -0.67 |
| Jun 30, 2021 | -0.13 |
| Mar 31, 2021 | -0.66 |